Diabetic Nephropathy

Kidney Biopsy Findings Predict Risk of Cardiovascular Events in CKD

Publish Date March 20, 2023

Histologic lesions in the kidney may reflect systemic processes that lead to cardiovascular events, according to investigators.

Glycated Albumin to HbA1c Ratio Predicts Death in Dialysis Population With Diabetes

Publish Date February 27, 2023

The ratio is a clinically meaningful indicator that is easily obtained from blood test results, according to investigators.

Triglyceride-Glucose Index Predicts Hyperuricemia in Diabetic Kidney Disease

Publish Date January 11, 2023

Early identification of patients at high risk of hyperuricemia using the triglyceride-glucose index may permit prompt intervention.

Personalized Screening for Kidney Disease Evaluated in Type 1 Diabetes

Publish Date November 29, 2022

Compared with annual screening for urinary albumin, personalized screening can reduce time spent with undetected albuminuria, testing frequency

Kidney Function Declines More Slowly With SGLT2 Inhibitor

Publish Date November 7, 2022

Treatment with an SGLT2 inhibitor may help patients with CKD or type 2 diabetes better preserve their kidney function.

Finerenone May Protect Against Pneumonia and COVID-19

Publish Date October 28, 2022

Finerenone, a mineralocorticoid receptor antagonist, may exert anti-inflammatory and anti-fibrotic effects, according to investigators.

Consensus Reached on Treating Diabetes in Chronic Kidney Disease

Publish Date October 17, 2022

The consensus report highlights shared guideline recommendations from the ADA 2022 Standards of Medical Care in Diabetes and KDIGO 2022 Clinical Practice Guideline for Diabetes Management in Chronic Kidney Disease.

SGLT2 Inhibitors, MRA Compared for Diabetic Kidney Disease

Publish Date July 21, 2022

Evidence in favor of SGLT2 inhibitors and nonsteroidal mineralocorticoid receptor antagonists for treating patients with diabetic kidney disease is growing.

Meta-Analysis Characterizes Benefits, Risks of Novel Nonsteroidal MRAs

Publish Date July 14, 2022

Blockading the mineralocorticoid receptor may be another strategy to treat CKD in patients with type 2 diabetes.

Team-Based Empowerment Care Improves Clinical Outcomes for Patients With Diabetic Kidney Disease

Publish Date June 30, 2022

A multicenter randomized controlled trial was conducted to assess the impact of a web-based, diabetes evaluation portal and team-based care on outcomes in patients with diabetic kidney disease.